Uncategorized

Many adults are sharing device data with their providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from health monitoring are less likely to adopt the tools, according to Rock Health.

Many adults are sharing device data with providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from health monitoring are less likely to adopt the tools, according to Rock Health.

Massachusetts’ life sciences jobs declined 1% in 2025, according to a new MassBioEd report. However, the report is projecting industry employment will increase 9.7% by 2030. It also noted reskilling needs for some roles, including scientists.

An acquisition of Independence would further expand West Virginia University Health System into southwestern Pennsylvania.

Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.

With Germany moving to curb healthcare spending, Eli Lilly and Boehringer Ingelheim have rethought plans to invest in facilities, including a manufacturing plant for GLP-1 drugs.

The advanced model should support earlier and more accurate diagnoses and treatment planning, the companies said.

Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.

In addition to a high rate of deaths, ADC Therapeutics’ Zynlonta plus rituximab showed no overall survival benefit in patients with diffuse large B cell lymphoma, casting doubt on its value as a second-line treatment in this indication.

Parabilis Medicines is joining the parade of biotechs going public, sharing plans to raise as much as $476.4 million to help advance its lead cancer candidate into late-stage testing.